Buscar
Mostrando ítems 1-10 de 98
Manejo fisioterapéutico en la optimización en la broncodilatación en ventilación mecánica invasiva
(2019-03-05)
La broncodilatación es el aumento del diámetro o de la luz de los bronquios, lo que permite un mayor flujo de aire hacia los pulmones por ellos el aporte de los broncodilatadores que son fármacos capaces de relajar el ...
Dexmedetomidine improves cardiovascular and ventilatory outcomes in critically ill patients: basic and clinical approaches
(Frontiers Media, 2020)
Dexmedetomidine (DEX) is a highly selective alpha 2-adrenergic agonist with sedative and analgesic properties, with minimal respiratory effects. It is used as a sedative in the intensive care unit and the operating room. ...
Dexmedetomidine Improves Cardiovascular and Ventilatory Outcomes in Critically Ill Patients: Basic and Clinical Approaches
(2020-02)
Dexmedetomidine (DEX) is a highly selective α2-adrenergic agonist with sedative and analgesic properties, with minimal respiratory effects. It is used as a sedative in the intensive care unit and the operating room. The ...
Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method
(2021)
Abstract
Background
Coronavirus disease 2019 (COVID-19) pandemic has caused unprecedented pressure on healthcare system globally. Lack of high-quality evidence on the ...
Intervención fisioterapéutica en síndrome de distres respiratorio agudo
(2018-12-06)
El Síndrome de Distres Respiratorio Agudo ocurre por una lesión de la membrana alveolocapilar que produce un aumento de la permeabilidad vascular pulmonar y la perdida de tejido pulmonar aireado; todo ello ocasiona que los ...
Intensive care management of patients with COVID‑19: a practical approach
(Jean-Louis Teboul, CHU Bicêtre, France, 2021)